Effect of d-chiro-inositol and alpha-lipoic acid combination on COH outcomes in overweight/obese PCOS women.
Observational StudyHuman subjects
Names both Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol in its title.
Supplement × Supplement·Evidence index
PubMed indexes 8 records that name Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.
Every statement below is attributed to a named, dated, linked source.
This page lists published research relevant to Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.
Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.
Names both Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol in its title.
Names both Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol in its title.
Names both Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol in its title.
“For the first time we reported that a combination of nutraceuticals composed of myo-inositol, alpha-lipoic acid, folic acid, betaine and vitamins improves sperm parameters in sub-fertile men. We are aware that to clarify the clinical relevance of the data studies with larger sample sizes and longer durations are needed, as well as evaluation of myo-inositol and alpha-lipoic acid co-treatment effectiveness in improving the chances to obtain a pregnancy spontaneously or…”
Names both Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol in its title.
“DCI plus ALA administration decreased AST and ALT and restored hepatic insulin clearance since HIE profile was improved.ConclusionOur study demonstrates that in overweight/obese PCOS the predisposition to familial diabetes triggers IR not only through the endogenous impaired DCI and ALA synthesis but also through a reduced hepatic clearance of insulin. DCI plus ALA administration positively improved hormonal, metabolic profiles as well as liver function.”
Names both Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol in its title.
Names both Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol in its title.
Names both Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol in its title.
“The association of d-chiro-inositol and alpha lipoic acid improves menstrual cycle length, restoring ovulation in the majority of women. Insulin sensitivity improved in women with IR only, confirming that in presence of IR the d-chiro-inositol has a role in restoring the insulin action overcoming the inactivity of epimerase in transforming myo-inositol to d-chiro inositol.”
Names both Alpha-Lipoic Acid and Myo-Inositol & D-Chiro-Inositol in its title.
Search-based evidence indexes have real limits, and it is worth being explicit about them:
NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Alpha-Lipoic Acid, Myo-Inositol & D-Chiro-Inositol, and several hundred other substances.
The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.